Showing results (91-100 of 146) with videos related to
Sort By:
Pageof 15
Environment International|July 15, 2022
Exposure of men living in the greater Montreal area to organophosphate esters: Association with hormonal balance and semen qualityShabana Siddique, Imen Farhat, Cariton Kubwabo, et al.American Heart Journal|July 29, 2008
Postmarket evaluation of breakthrough technologiesSunil V Rao, Robert M Califf, Judith M Kramer, et al.Clinical Epigenetics|January 7, 2023
Sperm DNA methylome abnormalities occur both pre- and post-treatment in men with Hodgkin disease and testicular cancerDonovan Chan, Kathleen Oros Klein, Antoni Riera-Escamilla, et al.Environment International|April 24, 2018
Exposure to polybrominated diphenyl ethers and phthalates in healthy men living in the greater Montreal area: A study of hormonal balance and semen qualityOcéane Albert, Jonathan Y Huang, Katarina Aleksa, et al.International Journal of Cardiology|February 21, 2015
Comparison of long-term safety and efficacy outcomes after drug-eluting and bare-metal stent use across racial groups: Insights from NHLBI Dynamic RegistryOladipupo Olafiranye, Helen Vlachos, Suresh R Mulukutla, et al.JAMA|May 10, 2007
Outcomes and complications associated with off-label and untested use of drug-eluting stentsNirat Beohar, Charles J Davidson, Kevin E Kip, et al.Optics Express|July 24, 2008
Field trial of 160 Gbit/s DWDM-based optical packet switching and transmissionHideaki Furukawa, Naoya Wada, Yoshinari Awaji, et al.American Journal of Men'S Health|October 26, 2021
Risky Business: Increasing Fertility Knowledge of Men in the General Public Using the Mobile Health Application Infotility XYKatya Kruglova, Eden Noah Gelgoot, Peter Chan, et al.Psycho-Oncology|September 4, 2018
A fertility needs assessment survey of male cancer patientsSamara Perez, Sylvie D Lambert, Virginia Lee, et al.JACC. Cardiovascular Interventions|May 26, 2009
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trialBernard Chevalier, Carlo Di Mario, Franz-Josef Neumann, et al.Pageof 15